Politics

Anvisa Collegiate Board has new composition defined after director's departure

Anvisa Collegiate Board has new composition defined after director's departure

29/12/2025

Marcelo Mario Matos Moreira takes over as substitute in the Fourth Board, filling the vacancy of the former rapporteur of the review of RDC 327

Anvisa approves new framework for herbal medicines in Brazil

Anvisa approves new framework for herbal medicines in Brazil

19/12/2025

New regulation simplifies registration and expands the use of biodiversity in herbal medicines, as soon as cannabis products are classified as medicines, they must comply with these standards.

Sergipe discusses expanding medical cannabis policy in SUS

Sergipe discusses expanding medical cannabis policy in SUS

18/12/2025

Meeting of the State Health Council discussed new protocols and free access to cannabis-based products in the public network

Anvisa prohibits sale and advertising of unregistered cannabis oil

Anvisa prohibits sale and advertising of unregistered cannabis oil

15/12/2025

Document sets regulatory priorities, including rules for cannabis cultivation, updates to resolutions, and adjustments to the sector's health framework

Cannabis cultivation and regulatory review take center stage in the 2026–2027 Regulatory Agenda

Cannabis cultivation and regulatory review take center stage in the 2026–2027 Regulatory Agenda

15/12/2025

Approved document defines 161 priority topics for the next two years, including national cultivation of low-THC cannabis

Santa Catarina: $1 million amendment strengthens supply of cannabidiol in SUS

Santa Catarina: $1 million amendment strengthens supply of cannabidiol in SUS

15/12/2025

Proposal included in the Multiannual Plan aims to organize access to cannabis-based medications and reduce litigation in the state

Anvisa suspends review of RDC 327 after director's request for further analysis

Anvisa suspends review of RDC 327 after director's request for further analysis

10/12/2025

Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence

Anvisa suspends review of RDC 327 after director's request for further analysis

Anvisa suspends review of RDC 327 after director's request for further analysis

10/12/2025

Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence

Anvisa to decide today the future of RDC 327 in a meeting that could redefine rules for cannabis products in Brazil

Anvisa to decide today the future of RDC 327 in a meeting that could redefine rules for cannabis products in Brazil

10/12/2025

Norm that regulates manufacturing, importation, prescription, and inspection may be entirely revoked and replaced by a new regulatory framework; decision will be made at the Collegiate Board meeting.

InCor and universities lead list of projects selected by Medicinal Cannabis Call

InCor and universities lead list of projects selected by Medicinal Cannabis Call

09/12/2025

With an investment of R$ 1.25 million, the initiative from São Paulo boosts studies in health, agriculture, veterinary, and social inclusion

Cannabis in the São Paulo public health system may advance later this year, with the inclusion of refractory spasticity multiple sclerosis

Cannabis in the São Paulo public health system may advance later this year, with the inclusion of refractory spasticity multiple sclerosis

08/12/2025

Deputy foresees document presentation in December, paving the way for treatment availability in 2026

Anvisa publishes proposal to update RDC 327 redefining rules for cannabis products in Brazil

Anvisa publishes proposal to update RDC 327 redefining rules for cannabis products in Brazil

06/12/2025

Draft presents new regulatory framework, tightens requirements for Sanitary Authorization, and prohibits manipulation of cannabis derivatives